{
    "2020-06-14": [
        [
            {
                "time": "2020-06-14",
                "original_text": "贝达药业:2.51亿元出售贝达医药科技全部股权 资产异常",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "出售",
                        "贝达医药科技",
                        "股权",
                        "2.51亿元"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-14",
                "original_text": "贝达药业(300558.SZ)：拟向实控人控制的公司出售贝达医药科技全部股权 控制人变化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "实际控制人",
                        "出售",
                        "贝达医药科技",
                        "股权"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-14",
                "original_text": "贝达药业：2.5亿元出售全资子公司贝达医药科技",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "出售",
                        "全资子公司",
                        "贝达医药科技",
                        "2.5亿元"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-14",
                "original_text": "贝达药业(300558.SZ)：贝伐珠单抗注射液(MIL60)上市许可申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝伐珠单抗注射液",
                        "MIL60",
                        "上市许可",
                        "申请受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}